NeoGenomics Inc (NAS:NEO)
$ 13.1 0.09 (0.69%) Market Cap: 1.67 Bil Enterprise Value: 1.88 Bil PE Ratio: 0 PB Ratio: 1.81 GF Score: 78/100

Q3 2019 Neogenomics Inc Earnings Call Transcript

Oct 29, 2019 / 12:30PM GMT
Release Date Price: $23.36 (+11.98%)
Operator

Good day, ladies and gentlemen, and welcome to the NeoGenomics Third Quarter 2019 Earnings Release Conference Call. (Operator Instructions) At this time, it's my pleasure to turn the floor over to Mr. Doug VanOort, Chairman and CEO. Mr. VanOort, the floor is yours.

Douglas M. VanOort
NeoGenomics, Inc. - Chairman & CEO

Well, thank you, Tom, and good morning, everyone. I'd like to welcome everyone to NeoGenomics Third Quarter 2019 Conference Call. Joining me from our Fort Myers headquarters is Rob Shovlin, President of our Clinical Division; George Cardoza, President of our Pharma Services Division; Bill Bonello, Chief Strategy and Corporate Development Officer and Director of Investor Relations; and Kathryn McKenzie, our Chief Accounting Officer. Before we begin our prepared remarks, Bill Bonello will read the standard language about forward-looking statements.

William Bishop Bonello
NeoGenomics, Inc. - Chief Strategy & Corporate Development Officer and Director of IR

This conference call may contain forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot